Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Discover the complete record of transactions filed by Oram Jeffrey, Director. Officer active across 1 company, notably Alzamend Neuro, Inc.. Aggregated, 3 disclosures have been logged. Activity tracked since 13 September 2021. The latest transaction was filed on 15 March 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Oram Jeffrey is a Board Member of Alzamend Neuro, Inc. In this role, he participates in the governance of the company and contributes to strategic decisions. His experience in the biotechnology sector is valuable for the development of Alzamend Neuro. As a board member, he ensures that the company meets its objectives and fulfills its commitments to customers and partners.